Trials / Completed
CompletedNCT03823222
Proteins From Duckweed Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Wageningen University and Research · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
This study aims to study the digestibility of isolated duckweed protein. The digestibility of the isolated duckweed protein will be compared to an isolated benchmark protein whey. Objective: The primary objective is to investigate the digestibility of isolated duckweed protein and the isolated benchmark protein whey. Study design: The study is a cross-over, double blind, controlled trial in which study participants will visit the research facility on two occasions under fasting conditions. Subjects will receive two protein sources in randomized order with a washout period of one week. Blood will be collected via a catheter before and up-to 3 hours after protein consumption. Study population: We aim to include 12 healthy volunteers aged 18-50 years. Intervention: Study participants will receive 20 grams of isolated duckweed protein and the isolated benchmark protein whey. Main study parameters/endpoints: The main study parameter is blood amino acids measured before and after consumption of 20 g protein.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Duckweed protein | 20 grams isolated protein |
| DIETARY_SUPPLEMENT | Whey protein | 20 grams isolated protein |
Timeline
- Start date
- 2019-02-28
- Primary completion
- 2019-03-28
- Completion
- 2019-03-28
- First posted
- 2019-01-30
- Last updated
- 2019-04-16
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT03823222. Inclusion in this directory is not an endorsement.